High Expertise - High Touch - High ImpactNelsen Biomedical team members work at a highly collaborative level bringing a valuable blend of expertise and real world experience to our clients. Our consultants are all industry veterans, experienced at growing life science companies from the inside out. We know that our success relies on a unique blend of our combined knowledge, skills and talents. We pledge to deliver outcomes with high impact. Outcomes achieved through extending your capabilities with our knowledge and networks. Our clients will attest to the passion we bring to each project and have even referred to Nelsen Biomedical as an "arm to their business".
“Barbara offers a wonderful
combination of strategic perspective
and a strong work ethic.”
Barbara Nelsen, PhD MBA
Barbara is the founder of Nelsen Biomedical, a consulting firm serving the life sciences industry. She brings over 20 years experience working on research, R&D management business and strategic development challenges within the biotechnology and pharmaceutical industries.
Barbara has deep experience working with innovative technologies and emerging industries.Previously in her career, Barbara was a partner in Northern Lights Seed Fund, a new venture initiative focused on seeding life science companies in Minnesota. Prior to this she was the Associate Director of Business Development for MGI Pharma, Inc. In this role, she was responsible for licensing activity and strategic partnerships. Prior to this, she was the Director of the Cancer Therapeutics Group at the Austin Research Institute in Melbourne, Australia, leading a team focused on developing novel diagnostics and therapeutics for cancer.
Barbara holds both a Ph.D. in molecular biology and an M.B.A. She serves on the Board of Discovery Capital, and is an active angel investor. She also is an advisor to life science start-ups at iPROPEL, part of the Illinois Biotechnology Institute, and the MN-REACH program.
Jeff brings over 25 years of Senior Executive experience from the Pharmaceutical and Medical Diagnostics arena. Areas of expertise include progressive sales, sales management, marketing, marketing management, new product development, market development and franchise leadership experience. Jeff's former positions inlcude General Manager of US Virology at Alere and Director of HIV Marketing at Bristol-Myers Squibb.
Joanne Chang, MBA
Joanne has over 10 years of experience in strategic and operations consulting in the pharmaceutical, medical device and health IT industries. She is a graduate of MIT and earned her MBA from Harvard. She has worked for Oliver Wyman, PRTM (now Price Waterhouse Cooper). Joanne has a strong life sciences startup background, including strategic finance, marketing and business development.
Margi brings over 25 years of business and marketing management. She received her Bachelors of Science degree from Butler University in Indianapolis. Her career includes both advertising agency side where she led account teams working with DuPont Pharma, Sandoz and MGI Pharma. She worked for MGI Pharma as Director of Marketing and then as the Business and Finance Manager for Quest Food Management, Inc. located just outside Chicago.
John R. MacDonald, Ph.D., DABT
John has had over 25 years of experience in all aspects of pharmaceutical drug development and licensing. He led the preclinical and clinical R&D efforts at MGI Pharma, a Twin Cities based oncology-focused company, from 1996 until retiring as Senior VP R&D at the end of 2005. At MGI John oversaw the FDA approval of several new drug candidates for the treatment of cancer, supportive care of cancer patients and patients with autoimmune disease. He served as a member of the MGI corporate management team that built the company through product and company acquisitions that culminated in the acquisition of MGI by Eisai, Inc.
John is a board certified toxicologist and prior to joining MGI worked in pathology and experimental toxicology in the Parke-Davis Research Division of Warner-Lambert participating in the early development of numerous well known therapeutics. He is currently active in drug development as the CEO of PepTx, Inc. John is an active consultant to pharmaceutical companies and academic institutions, serves of the Board of Discovery Capital, and is an advisor to the Institute for Therapeutics Discovery and Development at the University of Minnesota.
As part of our commitment to support innovative growth in the life sciences, we provide advisory services and domain expertise pro bono to the following incubators, government agencies and start-up organizations:
The Minnesota Angel Network
The Minnesota Angel Network was founded to accelerating the growth of emerging companies in Minnesota by educating entrepreneurs, connecting capital with investments, and catalyzing entrepreneurial success statewide. http://mnan.org
The Capital Network
The Capital Network is a non-profit organization that provides extensive financial education alongside an engaged community to help early-stage entrepreneurs in Boston. http://www.thecapitalnetwork.org
The Illinois BIO (iBIO) Institute’s PROPEL Center
The Illinois BIO (iBIO) Institute’s PROPEL Center's mission is to increase the number and success rates of life sciences start-ups in Illinois. http://www.ibiopropel.org
The Medical Industry Leadership Institute
University of Minnesota Carlson School of Management, driving innovation through cutting-edge leadership education, research, market development, industry-related experiential learning and partnerships with national health care and life science organizations. http://www.csom.umn.edu/medical-industry-leadership-institute/